[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@learnbiotech Avatar @learnbiotech Biotech Investor

Biotech Investor posts on X about abbv, $nvo, $abbv, $4503t the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance stocks cryptocurrencies

Social topic influence abbv #5, $nvo #7, $abbv #8, $4503t, $4523t, $gsk, drugs #130, $amgn, $fgen, ipo

Top assets mentioned Novo-Nordisk (NVO) AbbVie Inc (ABBV) GSK plc (GSK) Amgen, Inc. (AMGN) Cere Network (CERE) pNetwork (PNT) Merck & Co., Inc. (MRK) Anzen Finance (ANZ) Eli Lilly and Company (LLY) Metsera, Inc. Common Stock (MTSR)

Top Social Posts #


Top posts by engagements in the last XX hours

"Pharma has varying levels of success developing drugs. That's a boon for biotech Here are the biopharma companies ranked by likelihood of first approval (LoA%) from 2006-2022 $AMGN $NVO #Eisai top the list $GSK #Astellas $ABBV are at the bottom #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-07-20 12:01:01 UTC 5448 followers, 1445 engagements

"An #SOTP (Sum of the Parts) analysis is an important way to value a company w/multiple opportunities at different stages of development. Investors can see what the estimated relative value is on a per share basis. Ex for $FGEN #learnbiotechinvesting #investing #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-07-12 10:00:24 UTC 5443 followers, 1270 engagements

"Now w/ $PNT & $CERE Sometimes a #reversemerger or #SPAC can result in a high value ($1B) #biotech buyout. Both ways enable private companies to go public without an #IPO Here's a selected list: Any others I'm missing #learnbiotechinvesting #investing #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-04-01 09:01:06 UTC 5441 followers, 1011 engagements

"A reason to love #biotech: a company approaching the end (low stock price; near "death") can generate 20x return in a few or even X year Though these deals are few & far between here are some examples: Adding $VRNA/$MRK #learnbiotechinvesting #investing #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-07-14 10:00:44 UTC 5448 followers, 50.3K engagements

"Pharma has varying levels of success developing drugs. That's a boon for biotech Here are the biopharma companies ranked by likelihood of first approval (LoA%) from 2006-2022 $AMGN $NVO #Eisai top the list $GSK #Astellas $ABBV are at the bottom #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-06-05 10:00:57 UTC 5443 followers, 4472 engagements

"Amylin agonists are the next wave of #obesity drugs following the GLP-1s b/c they are likely to spare muscle Competition is intense with several mid-stage compounds: $LLY $NVO $ABBV $MTSR #ZEAL $ANZ Who will win #learnbiotechinvesting #biotech #investing #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-07-21 10:01:00 UTC 5448 followers, 3095 engagements

"Pharma has varying levels of success developing drugs. That's a boon for biotech Here are the biopharma companies ranked by likelihood of first approval (LoA%) from 2006-2022 $AMGN $NVO #Eisai top the list $GSK #Astellas $ABBV are at the bottom #BiotechPrometheus"
@learnbiotech Avatar @learnbiotech on X 2025-04-22 10:01:17 UTC 5439 followers, 8309 engagements